The Cell Therapy Development (CTD) Lab at UCSF's Mission Center Building accelerates the transition of cutting-edge cellular engineering technologies from the research lab to clinical applications. 

The facility is equipped with state-of-the-art GMP manufacturing equipment operated by our dedicated Process Development, Manufacturing, and Analytical Development teams.

Our rapidly iterative pre-clinical pipeline integrates innovative cellular engineering and delivery tools to advance new platforms directly into our GMP facilities. Products in development include a wide variety of viral and CRISPR-engineered T cell and hematopoietic stem cell therapies targeting cancer, infectious disease, inherited immune disorders, and transplant indications.